Literature DB >> 21522057

Behavioral effects of MDMA ('ecstasy') on adult zebrafish.

Adam Stewart1, Russell Riehl, Keith Wong, Jeremy Green, Jessica Cosgrove, Karoly Vollmer, Evan Kyzar, Peter Hart, Alexander Allain, Jonathan Cachat, Siddharth Gaikwad, Molly Hook, Kate Rhymes, Alan Newman, Eli Utterback, Katie Chang, Allan V Kalueff.   

Abstract

3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') is a potent psychedelic drug inducing euphoria and hypersociability in humans, as well as hyperactivity and anxiety in rodents. Adult zebrafish (Danio rerio) have become a widely used species in neurobehavioral research. Here, we explore the effects of a wide range (0.25-120 mg/l) of acute MDMA doses on zebrafish behavior in the novel tank test. Although MDMA was inactive at lower doses (0.25-10 mg/l), higher doses reduced bottom swimming and immobility (40-120 mg/l) and impaired intrasession habituation (10-120 mg/l). MDMA also elevated brain c-fos expression, collectively confirming the usage of zebrafish models for screening of hallucinogenic compounds.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21522057      PMCID: PMC3083639          DOI: 10.1097/FBP.0b013e328345f758

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  44 in total

Review 1.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 2.  The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.

Authors:  S R White; T Obradovic; K M Imel; M J Wheaton
Journal:  Prog Neurobiol       Date:  1996-08       Impact factor: 11.685

Review 3.  Mice in ecstasy: advanced animal models in the study of MDMA.

Authors:  Christophe P Stove; Els A De Letter; Michel H A Piette; Willy E Lambert
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

4.  The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain.

Authors:  C P Stephenson; G E Hunt; A N Topple; I S McGregor
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Characterization of behavioral and endocrine effects of LSD on zebrafish.

Authors:  Leah Grossman; Eli Utterback; Adam Stewart; Siddharth Gaikwad; Kyung Min Chung; Christopher Suciu; Keith Wong; Marco Elegante; Salem Elkhayat; Julia Tan; Thomas Gilder; Nadine Wu; John Dileo; Jonathan Cachat; Allan V Kalueff
Journal:  Behav Brain Res       Date:  2010-06-01       Impact factor: 3.332

6.  Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.

Authors:  M E Liechti; M R Saur; A Gamma; D Hell; F X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2000-10       Impact factor: 7.853

7.  Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio).

Authors:  Kelly Juliana Seibt; Renata da Luz Oliveira; Fernanda Francine Zimmermann; Katiúcia Marques Capiotti; Maurício Reis Bogo; Gabriele Ghisleni; Carla Denise Bonan
Journal:  Behav Brain Res       Date:  2010-06-20       Impact factor: 3.332

8.  Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice.

Authors:  Nadia Benturquia; Cindie Courtin; Florence Noble; Cynthia Marie-Claire
Journal:  Brain Res       Date:  2008-03-20       Impact factor: 3.252

9.  Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression.

Authors:  Joyce Colussi-Mas; Susan Schenk
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

10.  d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex.

Authors:  Chad J Reissig; Richard A Rabin; Jerrold C Winter; Cynthia A Dlugos
Journal:  Eur J Pharmacol       Date:  2008-01-07       Impact factor: 4.432

View more
  13 in total

1.  Spatial distribution of illicit drugs in surface waters of the natural park of Pego-Oliva Marsh (Valencia, Spain).

Authors:  Pablo Vazquez-Roig; Vicente Andreu; Cristina Blasco; Francisco Morillas; Yolanda Picó
Journal:  Environ Sci Pollut Res Int       Date:  2012-04-29       Impact factor: 4.223

2.  Controlled substances and innovation of biomedicine: a preclinical perspective.

Authors:  Adam Michael Stewart; Allan V Kalueff
Journal:  Nat Rev Neurosci       Date:  2013-10-23       Impact factor: 34.870

Review 3.  Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.

Authors:  Nikhil Neelkantan; Alina Mikhaylova; Adam Michael Stewart; Raymond Arnold; Visar Gjeloshi; Divya Kondaveeti; Manoj K Poudel; Allan V Kalueff
Journal:  ACS Chem Neurosci       Date:  2013-08-06       Impact factor: 4.418

4.  Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish.

Authors:  Evan Kyzar; Adam Michael Stewart; Samuel Landsman; Christopher Collins; Michael Gebhardt; Kyle Robinson; Allan V Kalueff
Journal:  Brain Res       Date:  2013-07-01       Impact factor: 3.252

Review 5.  Modeling anxiety using adult zebrafish: a conceptual review.

Authors:  Adam Stewart; Siddharth Gaikwad; Evan Kyzar; Jeremy Green; Andrew Roth; Allan V Kalueff
Journal:  Neuropharmacology       Date:  2011-08-09       Impact factor: 5.250

6.  Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology.

Authors:  Evan J Kyzar; Christopher Collins; Siddharth Gaikwad; Jeremy Green; Andrew Roth; Louie Monnig; Mohamed El-Ounsi; Ari Davis; Andrew Freeman; Nicholas Capezio; Adam Michael Stewart; Allan V Kalueff
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-09       Impact factor: 5.067

7.  Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors.

Authors:  Luisa Ponzoni; Daniela Braida; Mariaelvina Sala
Journal:  Psychopharmacology (Berl)       Date:  2016-06-18       Impact factor: 4.530

8.  Gene alteration in zebrafish exposed to a mixture of substances of abuse.

Authors:  B Subedi; S Anderson; T L Croft; E C Rouchka; M Zhang; D R Hammond-Weinberger
Journal:  Environ Pollut       Date:  2021-02-24       Impact factor: 9.988

9.  A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

Authors:  Devahuti Chaliha; John C Mamo; Matthew Albrecht; Virginie Lam; Ryu Takechi; Mauro Vaccarezza
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 10.  Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish.

Authors:  Giancarlo Bruni; Parth Lakhani; David Kokel
Journal:  Front Pharmacol       Date:  2014-07-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.